MedImmune, LLC - Strategic SWOT Analysis Review

MedImmune, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

MedImmune, LLC (MedImmune), is a biotechnology company operating as the global biologics subsidiary of AstraZeneca. It focuses on the research, development, manufacture and marketing of biologics to address some of the major medical needs. The company develops therapeutic proteins, monoclonal antibodies and other next-generation molecules targeting diseasing the areas of oncology; respiratory, inflammation and autoimmune; and cardiovascular and metabolic diseases. The company’s product portfolio includes products for respiratory syncytial virus; influenza vaccine; and organic thiophosphate cytoprotective agent. The company operates three R&D centers in Gaithersburg, Maryland; Cambridge, the UK; and Mountain View, California. MedImmune is headquartered in Gaithersburg, Maryland, the US.

MedImmune, LLC Key Recent Developments

Oct 13, 2015: Human Vaccines Project Partners with MedImmune to Help Accelerate Research and Development in Infectious Disease and Oncology
Sep 11, 2015: Cancer Research UK and MedImmune launch ground-breaking biotherapeutics research centre in Cambridge
Jul 21, 2015: Dr. David Berman Joins Medimmune as Head of Oncology
Jul 14, 2015: Medimmune Appoints Diabetes Researcher Dr. Christopher Rhodes As Head Of Cardiovascular And Metabolic Disease Research
Mar 30, 2015: Maryland Regional Biotech Forum Aims to Propel Washington, D.C. Metro Region to a Top Three Ranked U.S. Biotech Hub by 2023

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Frequently Asked Questions